Around five percent of people who have had COVID-19 develop long-lasting problems with their sense of smell or taste, a large study said Thursday, potentially contributing to the burden of long COVID.
A lost sense of smell has been a hallmark of contracting coronavirus since the early days of the pandemic, but it has not been clear how often symptoms like this occur—or how long they can last.
Seeking to find out, researchers analyzed the findings of 18 previous studies involving 3,700 patients.
In a new study published in the BMJ, they found that six months after contracting the virus, four percent of patients had not recovered their sense of smell. Meanwhile, two percent had not recovered their sense of taste.
It was unclear if this represented a full or partial recovery, however.
The researchers estimated that loss of smell may persist in 5.6 percent of patients, while 4.4 percent may not fully recover their sense of taste.
One woman told the researchers that she had not recovered her sense of smell more than two years after contracting COVID.
The researchers said that while most patients should recover their sense of smell and taste within the first three months of getting COVID, “a major group of patients might develop long-lasting dysfunction”.
“That (may require) timely identification, personalized treatment, and long-term follow-up.”
Danny Altmann, an immunologist at Imperial College London not involved in the research, said it was a “strong and important study”.
“Studies such as this alert us to the hidden burden out there of people suffering with persistent symptoms, but perhaps not having thought it worth contacting the GP on the assumption there wouldn’t be much to be done,” he said.
The research also found that women were less likely to recover these senses than men.
The cause of the disparity is not clear, but the researchers suggested women tend to have better senses of smell and taste in the first place, meaning they have more to lose.
The data did not include which COVID variant the patients contracted. Previous research has indicated that more recent Omicron variants are less likely to lead to smell loss.
more recommended stories
Uncovering the skin’s secrets: Studies show how skin forms differently across the body
Why are certain body parts more.
Diets rich in refined fiber may increase liver cancer risk in some individuals
Many people commonly consume fiber-enriched foods.
Resistance-breathing training found to lower blood pressure
A team of researchers with members.
COVID-19 associated with increase in new diagnoses of type 1 diabetes in youth, by as much as 72%
Children who were infected with COVID-19.
Healthy lifestyle may help former smokers lower their risk of death from all causes
Former smokers who stick to a.
Night-time blood pressure assessment is important in diagnosing hypertension
Around 15% of people aged 40–75.
Transition to newer clot-busting drug improves patient outcomes, lowers cost in treating ischemic stroke
A newer-generation clot-busting drug called tenecteplase.
Artificial intelligence tools quickly detect signs of injection drug use in patients’ health records
An automated process that combines natural.
New imaging technique could speed up development of eye disease treatments
Researchers have developed a simple and.
Grassroots effort redefines cardiogenic shock, a deadly heart condition: Findings could change treatments
Cardiogenic shock is not a heart.